Table 6. Prognostic value of different subpopulations of dendritic cells on overall survival in IBC patients.

Variable	HR	95% Lower CI	95% Upper CI	p - value
DC	1.13	0.61	2.11	0.70
mDC in DC	0.63	0.34	1.17	0.14
pDC in DC	0.72	0.39	1.34	0.30
CCR5 in mDC	0.75	0.4	1.39	0.36
CCR5 in pDC	1.02	0.55	1.9	0.95
CCR7 in mDC	1.06	0.57	1.97	0.85
CCR7 in pDC	1.26	0.66	2.4	0.51
mDC_TNF-α.TLR	0.41	0.22	0.77	0.004
mDC_TNF-α.US	0.63	0.34	1.16	0.14
pDC_TNF-α.TLR	0.82	0.44	1.51	0.51
pDC_TNF-α.US	1.91	1	3.63	0.08
mDC_IFN-α.TLR	0.72	0.39	1.33	0.28
mDC_IFN-α.US	1	0.54	1.85	0.99
pDC_IFN-α.TLR	0.79	0.43	1.47	0.45
pDC_IFN-α.US	1.2	0.62	2.34	0.60
mDC_IL-12.TLR	0.92	0.49	1.72	0.79
mDC_IL-12.US	0.6	0.32	1.13	0.11
pDC_IL-12.TLR	0.64	0.34	1.2	0.16
pDC_IL-12.US	1.06	0.54	2.07	0.87
mDC_IL-10.TLR	1.22	0.66	2.25	0.52
mDC_IL-10.US	1.29	0.7	2.38	0.42
pDC_IL-10.TLR	1.1	0.59	2.03	0.77
pDC_IL-10.US	1.4	0.76	2.6	0.27
CCR5_in_mDC.TLR	1.29	0.69	2.42	0.42
CCR5_in_mDC.US	1.54	0.82	2.9	0.17
CCR5_in_pDC.TLR	1.67	0.89	3.14	0.11
CCR5_in_pDC.US	1.35	0.72	2.55	0.34
CCR7_in_mDC.TLR	0.84	0.45	1.57	0.58
CCR7_in_mDC.US	1.19	0.63	2.23	0.59
CCR7_in_pDC.TLR	1.4	0.74	2.63	0.29
CCR7_in_pDC.US	0.91	0.48	1.71	0.77
CD80_in_mDC.TLR	1.04	0.56	1.96	0.89
CD80_in_mDC.US	0.66	0.35	1.24	0.17
CD80_in_pDC.TLR	0.72	0.38	1.34	0.29
CD80_in_pDC.US	0.59	0.3	1.16	0.09
CD86_in_mDC.TLR	0.98	0.52	1.83	0.95
CD86_in_mDC.US	0.66	0.35	1.25	0.20
CD86_in_pDC.TLR	0.66	0.35	1.25	0.19
CD86_in_pDC.US	0.88	0.47	1.65	0.69

* all immune cells subpopulation were dichotomized as “low” or “high” based on median value of percentage of immunes cells in all patients. All hazard ratios are based on comparison of “low” vs. “high” groups.